Alpha Tau Medical (DRTS) Short-term Investments (2020 - 2026)

Alpha Tau Medical has disclosed Short-term Investments across 7 years of filings, most recently posting $71.8 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $71.8 million, up 53.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.8 million (up 53.98% YoY), and the FY2025 annual result was $60.9 million, up 32.8% from the prior year.
• Short-term Investments came in at $71.8 million for Q1 2026 at Alpha Tau Medical, up from $60.9 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $8.1 billion in Q1 2022 to a low of $45.9 million in Q4 2024.
• The 5-year median for Short-term Investments is $70.3 million (2024), against an average of $547.1 million.
• Across the five-year window, Short-term Investments surged 1121.46% in 2022 and tumbled 98.78% in 2023, its largest moves.
• Alpha Tau Medical's Short-term Investments stood at $98.7 million in 2022, then declined by 29.95% to $69.1 million in 2023, then plunged by 33.64% to $45.9 million in 2024, then soared by 32.8% to $60.9 million in 2025, then gained by 17.82% to $71.8 million in 2026.
• The last three Short-term Investments figures came in at $71.8 million (Q1 2026), $60.9 million (Q4 2025), and $68.9 million (Q3 2025), per Business Quant data.